Sterne Agee Downgrades Salix Pharmaceuticals (SLXP) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St slips on rising bond yields; Walmart results weigh
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Shire Preparing Bid for Salix Pharma - Reuters (SHPG) (SLXP) (VRX)
February 13, 2015 6:40 AM ESTFollowing on the heals of a Bloomberg article yesterday that said Valeant Pharma (NYSE: VRX) secured financing for a Salix Pharma (NASDAQ: SLXP) bid, Reuters sources said Shire (NASDAQ: SHPG) is working with advisers on a potential offer and is evaluating how to secure financing.
... MoreUPDATE: Valeant Pharma (VRX) Secures Financing for Salix (SLXP) Offer - Bloomberg
February 12, 2015 1:37 PM EST(Updated - February 12, 2015 1:45 PM EST)
(Updated - February 12, 2015 1:39 PM EST)
Valeant Pharma (NYSE: VRX) secured financing for a Salix (Nasdaq: SLXP) offer that is said to be over $150 per share, according to... More
